Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs,supporting potential for improved protection against infection ...

Today on AirTalk, an update on COVID-19 funding and the latest on the future of vaccination efforts, the American Society of ...

In the US, the CDC recommends shingles vaccination for all adults aged 50 and older. However, uptake has been low, partly due to limited awareness, cost concerns, and missed opportunities during ...

Health Secretary Robert F. Kennedy Jr.’s cut to funding for mRNA research will also hurt the nation’s reputation as a leader ...

Food prices rise, FDA considers revoking children's COVID vaccine approval, social security adjustment expected, Kodak's ...

I’ve spent a lot of time with a knot of anxiety in my stomach lately as I’ve followed the rapid-fire pace of changes happening to health care and the systems that govern it. Like many of you, I’ve had ...

It is baseless, and we will pay a tremendous price in terms of illnesses and deaths.” That brutal judgment by Michael ...

CDC security guards stopped White from driving into the campus on Friday before he parked near a pharmacy across the street ...

Discover key insights from Arcturus Therapeutics' Q2 2025 earnings call, featuring updates on CF and OTC programs, vaccine progress, and ...

HHS Secretary RFK Jr. sat down with Scripps News for a wide-ranging interview, discussing mRNA vaccine funding policy changes ...

I don’t know what we’re supposed to do,” said Aaron Hardwick, who tested positive for COVID-19 in June. “Can we get the shot?

A Fallen Giant Pfizer (NYSE:PFE) has been a bitter pill for investors to swallow. Down 19% from its 52-week high of $30.43 per share, PFE stock has plummeted over 50% in the past three years, a stark ...